US 12281060
Remodilins for airway remodeling and organ fibrosis
granted A61KA61K31/18A61K31/63
Quick answer
US patent 12281060 (Remodilins for airway remodeling and organ fibrosis) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/18, A61K31/63, A61K31/635, A61K45/06